 |
市场调查报告书
商品编码
2008185
生物製药生产一次性系统市场：依生物反应器、应用、生物製程、产品、模式、组件和地区划分Single Use System in Biopharma Manufacturing Market, By Bioreactors, By Application, By Bioprocessing, By Product, By Modality, By Component, By Geography |
||||||
价格
简介目录
预计到 2026 年，生物製药生产的一次性系统市场规模将达到 180 亿美元，到 2033 年将达到 683.5 亿美元。预计 2026 年至 2033 年的复合年增长率将达到 20.8%。
| 分析范围 | 分析详情 | ||
|---|---|---|---|
| 基准年 | 2025 | 市场规模（2026 年） | 180亿美元 |
| 效能数据 | 2020-2024 | 预测期 | 2026-2033 |
| 预测期（2026-2033 年）复合年增长率 | 20.80% | 预计金额（2033 年） | 683.5亿美元 |
一次性使用系统（SUS）是指专为一次性使用和处置而设计的生物製药生产设备。这些系统正日益成为生物製药生产中不銹钢设备的替代方案。一次性使用技术为生物製药的生产提供了一种高效且经济的方式。简而言之，一次性使用系统和技术为满足生物製药研发和生产中的生物製程需求提供了解决方案。例如，全球生物製药公司正在采用一次性使用系统来生产药品和疫苗。
市场动态
政府对生物相似药和生技药品的支持力度加大，生物製药的接受度和需求不断提高，生物製药能够治疗难治性疾病，以及生物製药製造业的成长，这些都是推动全球生物製药生产一次性系统市场成长的主要因素。
2021 年 2 月，百时美施贵宝授予洛克斐勒独家许可，开发、生产和商业化一种新型单株抗体双疗法，用于中和 SARS-CoV-2 病毒，以治疗或预防 COVID-19。
此外，2020 年 3 月，赛默飞世尔科技投资约 4.75 亿美元，用于扩大其生技药品、细胞疗法、基因疗法和药物开发设施，并增强其全球商业能力。
本报告的主要特点
- 本报告指出了各个细分市场的潜在商机，并描述了该市场中一系列有吸引力的投资提案。
- 此外，它还提供了有关市场驱动因素和限制因素、机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的重要见解。
- 本节根据以下参数介绍全球生物製药生产一次性系统市场中主要企业的概况：公司概况、产品系列、主要亮点、财务表现和策略。
- 本报告中的见解将使负责人和企业经营团队能够就未来的产品发布、产品线更新、市场扩张和行销策略做出明智的决策。
- 《全球生物製药生产一次性系统市场》报告面向该行业的各种相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
- 相关人员可以透过分析全球生物製药生产一次性系统市场中使用的各种策略矩阵来促进决策。
目录
第一章：分析目标与假设
- 分析目的
- 先决条件
- 简称
第二章 市场展望
- 报告说明
- 市场定义和范围
- 执行摘要
- Coherent Opportunity Map（COM）
第三章：市场动态、监管与趋势分析
- 市场动态
- 全球对生物製药的需求不断成长
- 先进製造要求
- 对安全有效药品和疫苗的需求日益增长
- 影响分析
- 主要亮点
- 法规环境
- 产品上市及核准
- PEST分析
- 波特五力分析
- 企业合併趋势
第四章：全球生物製药生产一次性系统市场：依生物反应器划分（2026-2033 年）
- 小于1000公升
- 1000～2000L
- 超过2000公升
第五章：全球生物製药生产一次性系统市场：按应用领域划分（2026-2033 年）
- 过滤
- 储存（缓衝溶液和培养基的储存、冷冻和解冻）
- 细胞培养
- 混合物
- 纯化
- 无菌灌装
第六章：全球生物製药生产一次性系统市场：依生物製程划分（2026-2033 年）
- 小规模
- 中号
- 大规模
第七章 全球生物製药生产一次性系统市场：依产品划分（2026-2033 年）
- 采样系统
- 生物製程容器
- 生物反应器
- 混合器
- 膜吸收器
- 瓶子
- 装置
- 传输单元
- 其他物品（一次性滤芯（DFC）、深层过滤器、夹具等）
第八章：全球生物製药生产一次性系统市场：按模式划分（2026-2033 年）
- 蛋白质、单株抗体（Mab）
- 细胞疗法
- 基因治疗
- 传统疫苗
- mRNA
第九章：全球生物製药生产用一次性系统市场：按组件划分（2026-2033 年）
- 原料药
- 配方
第十章：全球生物製药生产用一次性系统市场：按地区划分（2026-2033 年）
- 北美洲
- 我们
- 加拿大
- 欧洲
- 德国
- 英国
- 法国
- 义大利
- 西班牙
- 俄罗斯
- 其他欧洲国家
- 亚太地区
- 中国
- 印度
- 日本
- 澳洲
- 韩国
- ASEAN
- 其他亚太地区
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
- 中东和非洲
- GCC
- 以色列
- 南非
- 中非
- 其他中东和非洲地区
- 其他地区（ROW）
第十一章 竞争格局
- Getinge AB
- Rentschler Biopharma SE
- Kuhner AG
- Danaher Corporation
- Merck KgaA
- Lonza
- PBS Biotech Inc.
- ThermoFisher Scientific
- Corning Incorporated
- Eppendorf
- Entegris
- Pall Corporation
- Sartorius AG（Sartorius Stedim Biotech）
第十二章
- 分析方法
- 关于 Coherent Market Insights
简介目录
Product Code: CMI5228
Single Use System In Biopharma Manufacturing Market is estimated to be valued at USD 18,000 Mn in 2026 and is expected to reach USD 68,350 Mn by 2033, growing at a compound annual growth rate (CAGR) of 20.8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 18,000 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 20.80% | 2033 Value Projection: | USD 68,350 Mn |
Single use systems (SUS) refers to biopharmaceutical manufacturing equipment designed to be used once and then discarded. These systems are being increasingly used as an alternative to stainless-steel equipment for biopharma manufacturing. Single-use technologies offer both efficient & cost-effective way to manufacture biopharmaceuticals. In short, single use systems or technologies provide solutions that address the bioprocessing needs in the development and manufacturing of biopharmaceuticals. For instance, biopharmaceutical companies worldwide use single-use system to manufacture drugs and vaccines.
Market Dynamics
Rising government support towards biosimilar & biological drugs, increasing acceptance and demand for biopharmaceuticals, ability of biopharmaceuticals to treat untreatable diseases, and growing biopharmaceutical manufacturing industry are some major factors expected to aid in the growth of the global single use system in biopharma manufacturing market.
In February 2021, Bristol Myers Squibb granted an exclusive license to develop, manufacture, and commercialize Rockefeller's novel monoclonal antibody duo treatment that neutralizes the SARS-CoV-2 virus for therapy or prevention of COVID-19.
Moreover, in March 2020, Thermo Fisher Scientific Inc. invested around US$ 475 million to expand its biologics, cell therapy and gene therapy, and drug product development facilities and increase its global commercial capabilities.
Key features of the study
- This report provides in-depth analysis of the global single use system in biopharma manufacturing market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global single use system in biopharma manufacturing market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Getinge AB, Rentschler Biopharma SE, Kuhner AG, Danaher Corporation, Merck KgaA, Lonza, PBS Biotech Inc., ThermoFisher Scientific, Corning Incorporated, Eppendorf, Pall Corporation, Entegris, and Sartorius AG (Sartorius Stedim Biotech), among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global single use system in biopharma manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global single use system in biopharma manufacturing market.
Market Segmentation
- By Bioreactors
- Less than 1000L
- 1000-2000L
- More than 2000L
- By Application
- Filtration
- Storage (Buffer & Media Storage, Freeze & Thaw)
- Cell Culture
- Mixing
- Purification
- Aseptic Filling
- By Bioprocessing
- Small-scale
- Mid-scale
- Large-scale
- By Product
- Sampling Systems
- Bioprocess Containers
- Bioreactors
- Mixers
- Membrane Absorbers
- Bottles
- Equipment
- Transfer Units
- Others (Disposable filter Cartridges (DFC), Depth Filters, Clamps etc.)
- By Modality
- Protein & Monoclonal Antibody (Mab)
- Cell Therapy
- Gene Therapy
- Conventional Vaccine
- mRNA
- By Component
- Drug Substance
- Drug Product
- By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players
- Getinge AB
- Rentschler Biopharma SE
- Kuhner AG
- Danaher Corporation
- Merck KgaA
- Lonza
- PBS Biotech Inc.
- ThermoFisher Scientific
- Corning Incorporated
- Eppendorf
- Pall Corporation
- Entegris
- Sartorius AG (Sartorius Stedim Biotech)
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Bioreactors
- Market Snippet, By Application
- Market Snippet, By Bioprocessing
- Market Snippet, By Product
- Market Snippet, By Modality
- Market Snippet, By Component
- Market Snippet, By Geography
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Increasing demand for biopharmaceuticals across the globe
- High-end manufacturing requirements
- Increasing demand for safe and effective drugs and vaccines
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Single Use System in Biopharma Manufacturing Market, By Bioreactors, 2026-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Less than 1000L
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- 1000-2000L
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- More than 2000L
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
5. Global Single Use System in Biopharma Manufacturing Market, By Application, 2026-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Filtration
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- Storage (Buffer & Media Storage, Freeze & Thaw)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- Cell Culture
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- Mixing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- Purification
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- Aseptic Filling
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
6. Global Single Use System in Biopharma Manufacturing Market, By Bioprocessing, 2026-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Small-scale
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- Mid-scale
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- Large-scale
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
7. Global Single Use System in Biopharma Manufacturing Market, By Product, 2026-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Sampling Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- Bioprocess Containers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- Bioreactors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- Mixers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- Membrane Absorbers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- Bottles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- Equipment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- Transfer Units
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- Others (Disposable filter Cartridges (DFC), Depth Filters, Clamps etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
8. Global Single Use System in Biopharma Manufacturing Market, By Modality, 2026-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Protein & Monoclonal Antibody (Mab)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- Gene Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- Conventional Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- mRNA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
9. Global Single Use System in Biopharma Manufacturing Market, By Component, 2026-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Drug Substance
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
- Drug Product
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033,(USD Mn)
10. Global Single Use System in Biopharma Manufacturing Market, By Geography, 2026-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Bioreactors, 2026-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Bioprocessing, 2026-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Modality, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2026-2033, (USD Mn)
- US
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Bioreactors, 2026-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Bioprocessing, 2026-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Modality, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2026-2033, (USD Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Bioreactors, 2026-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Bioprocessing, 2026-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Modality, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2026-2033, (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Bioreactors, 2026-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Bioprocessing, 2026-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Modality, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2026-2033, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East and Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Bioreactors, 2026-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Bioprocessing, 2026-2033,(USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Modality, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2026-2033, (USD Mn)
- GCC
- Israel
- South Africa
- Central Africa
- Rest of Middle East and Africa
- Rest of World
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Bioreactors, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Bioprocessing, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Modality, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2026-2033, (USD Mn)
11. Competitive Landscape
- Getinge AB
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Rentschler Biopharma SE
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Kuhner AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Danaher Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KgaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lonza
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PBS Biotech Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- ThermoFisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Corning Incorporated
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Eppendorf
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Entegris
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pall Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sartorius AG (Sartorius Stedim Biotech)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
12. Section
- Research Methodology
- About us
